Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GSK 2321138A

Next Previous
X
Search
Drug Profile

GSK 2321138A

Alternative Names: a-RIX-Tetra; FLU D-QIV; Fluarix Quadrivalent; Fluarix Tetra; Fluarix Tetra 2013/2014; FluarixTetra; GSK-2321138A; IIV4 - GSK; Inactivated quadrivalent influenza vaccine - GSK; Influsplit Tetra; Influsplit Tetra 2013/2014; Quadrivalent influenza vaccine – GSK

Latest Information Update: 22 Feb 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GlaxoSmithKline
  • Developer GlaxoSmithKline; GSK
  • Class Antivirals; Influenza virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Influenza virus infections

Most Recent Events

  • 22 Feb 2023 Discontinued - Phase-III for Influenza virus infections (In the elderly, Prevention, In adults) in Brazil (IM)
  • 15 Jul 2021 GlaxoSmithKline Biologicals initiates enrolment in the phase III RSV MAT-010 trial (In volunteers, Prevention) in Finland (IM, Injection) in July 2021 (EudraCT2021-000357-26)
  • 11 Sep 2018 No development reported - Phase-III for Influenza virus infections (In children, In infants, Prevention) in Bangladesh, Turkey, India, Lebanon, Honduras, Dominican Republic, Thailand, Philippines, Brazil (IM)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top